Clinical Trial Patient Recruitment Services Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 3.26 Billion |
| Market Size (2029) | USD 4.84 Billion |
| CAGR (2024 - 2029) | 8.22 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Clinical Trial Patient Recruitment Services Market Analysis
The Clinical Trial Patient Recruitment Services Market size is estimated at USD 3.26 billion in 2024, and is expected to reach USD 4.84 billion by 2029, at a CAGR of 8.22% during the forecast period (2024-2029).
The growing number of clinical studies globally is one of the key reasons supporting the demand for clinical trial patient recruitment services. As clinical trials expand across various therapeutic areas, the demand for patient recruitment services is likely to surge in the coming years. With a rise in the development of novel therapies and treatments, effective recruitment strategies are needed to enroll suitable participants for these trials, which is likely to drive the market's growth during the forecast period.
For instance, data from ClinicalTrials.gov in October 2024 indicated approximately 512,338 ongoing clinical trials worldwide, with 153,133 based in the United States. As the same source mentioned, over 512,000 clinical trials are underway worldwide, with a significant concentration in the United States, underscoring a robust demand for patient recruitment services to streamline participant enrollment. The sheer volume of trials necessitates specialized services to identify, engage, and recruit suitable participants, which is expected to drive market growth.
Furthermore, the growing burden of diseases needs more advanced and effective medicines for treatment, which is projected to contribute to market growth. For instance, data from the World Health Organization, released in February 2024, forecasts over 35 million new cancer cases by 2050. This marks a staggering 77% rise from the estimated 20 million cases in 2022. Moreover, as per June 2023 data from the Institute for Health Metrics and Evaluation, diabetes cases are projected to soar from 529 million in 2023 to 1.3 billion by 2050. The rising prevalence of diseases necessitates the development of novel treatment options, prompting pharmaceutical and biotech companies to conduct more clinical trials to test the efficacy and safety of new therapies. This surge in clinical trial activity is likely to drive the demand for patient recruitment services to identify and enroll suitable participants.
Therefore, increasing prevalence of diseases and robust investigational pipeline, the market is anticipated to grow over the forecast period. However, the market's growth may be stunted by individuals' limited awareness of clinical studies and pharmaceutical companies' insufficient budgeting for patient enrollment.
Clinical Trial Patient Recruitment Services Market Trends
Phase III Segment is Expected to Show Better Growth in the Forecast Years
Phase III clinical trials assess how a new medication compares to existing treatments, while also confirming and expanding upon the safety and effectiveness findings from Phases 1 and 2. This phase of clinical trial usually involves up to 3,000 participants with the condition that the new medication is meant to treat and may last for many years. Also, the number of volunteers in Phase III clinical trials is comparatively higher than in Phase II and Phase I trials, owing to their greater complexity and need for a larger patient pool. Factors such as increasing research activities, the growing burden of diseases, and many investigational drug candidates in Phase III are projected to propel the segment’s growth over the coming years.
The high number of drugs in Phase III of a clinical trial is projected to drive the growth of the segment. For instance, according to the data from clinicaltrials.gov, as of December 2024, around 2,092 active studies were in Phase III, and among them, most were for cancer, autoimmune diseases, and other chronic conditions like rare diseases and cardiovascular conditions. Thus, such a high number of clinical trials in Phase III of clinical trials is expected to contribute to the segment's growth.
Moreover, launches of clinical trial patient recruitment services, with emphasis on phases III, are likely to drive segment growth. For instance, in June 2022, Walgreens entered the clinical trial business and launched a service to provide pharmaceutical companies with patient recruitment and enrollment services.Well-known brands entering the clinical trial patient recruitment space can enhance the credibility and trust associated with these services. Patients may be more willing to participate in Phase III trials facilitated by reputable organizations like Walgreens, thereby streamlining the recruitment process.
Consequently, the introduction of clinical trial services and the rising number of Phase III trials are key factors propelling the growth of this segment.
North America is Expected to Dominate the Clinical Trial Patient Recruitment Services Market
North America's market is poised for significant growth, primarily due to the region's high volume of ongoing clinical trials. This growth is further bolstered by substantial investments in R&D and robust government backing for these trials. Additionally, the market's expansion in North America is underscored by the presence of prominent contract research organizations that provide a range of services, including patient recruitment, and the active involvement of multinational pharmaceutical and biopharmaceutical firms.
The rising number of new cancer cases diagnosed annually and the increasing prevalence of diseases such as diabetes underscore the urgent need for advanced treatment options and therapies. Clinical trials play a crucial role in evaluating and developing innovative treatments for chronic diseases, driving the demand for patient recruitment services to enroll participants in these trials. For instance, according to the American Cancer Society's 2023 update, around 1.93 million new cancer cases were diagnosed in 2023, compared to 1.9 million cases in 2022 in the United States. Additionally, Furthermore, the Parkinson's Foundation projects that by 2030, 1.2 million individuals in the United States will be diagnosed with Parkinson's disease.
The demand for novel therapies to address the increasing burden of chronic diseases drives the pace of drug development in these areas. Patient recruitment services facilitate the enrollment of participants in clinical trials, expediting the drug development process and enabling faster access to potentially life-saving treatments for patients with chronic conditions. This is likey to drive the growth of the clinical trial patient recruitment services market in the region. For instance, in November 2024, UCSF Benioff Children’s Hospital Oakland began enrolling patients in a groundbreaking clinical trial aimed at curing sickle cell disease. This trial marks the first time the United States has utilized non-viral CRISPR-Cas9 gene-editing technology on humans to directly amend the genetic mutation responsible for the disease. Such pioneering trials are likely to attract increased attention from both patients and researchers, driving up the demand for novel therapies and accelerating the pace of drug development for chronic diseases. As a result, the need for patient recruitment services to enroll participants in these innovative clinical trials will surge.
Moreover, introduction of clinical trial support solutions by the key players is also likely to drive the region's growth. For instance, in September 2024, ImageBloom, Inc., a frontrunner in clinical trial support solutions, proudly unveiled the patient recruitment marketplace. This pioneering platform aimed to transform the patient recruitment landscape for clinical research sites. With the Patient Recruitment Marketplace, research teams can swiftly tap into an extensive library of pre-prepared marketing materials, enhancing recruitment efficiency and expediting clinical trials in the United States.
Thus, launches of new supportive platform for patient recruitment and increasing burden of chronic diseases that demand new drug development which boost the clinical trails demand which in trun the drive the clinical trial patient recruitment services market in the North America region.
Clinical Trial Patient Recruitment Services Industry Overview
The clinical trial patient recruitment services market is moderately competitive and consists of a few major players. Companies like ICON plc, IQVIA, AutoCruitment, ClinicalConnection, Antidote Technologies, Inc., and BBK Worldwide hold substantial market shares in the clinical trial patient recruitment services market. To maintain stability in the market, major players undertake key strategic initiatives, such as new service launches, acquisitions, collaborations, and regional expansions.
Clinical Trial Patient Recruitment Services Market Leaders
-
ICON plc
-
BBK Worldwide
-
Antidote Technologies, Inc.
-
IQVIA
-
ClinicalConnection
*Disclaimer: Major Players sorted in no particular order
Clinical Trial Patient Recruitment Services Market News
- April 2024: AutoCruitment introduced an AI-driven electronic medical record (EMR) system designed to enhance patient recruitment services. This innovative technology simplifies the processes of consent, capture, standardization, and review of electronic medical records, benefiting both clinical research sites and patients.
- September 2024: MRN, a global leader in home trial support services, launched its home trial services in India to support clinical trails.
Clinical Trial Patient Recruitment Services Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Number of Clinical Trials Globally
4.2.2 Demand for Diverse Patient Populations
4.3 Market Restraints
4.3.1 Patient Concerns About Risks and Side Effects
4.3.2 Complex Inclusion/Exclusion Criteria of Patient
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Phase
5.1.1 Phase I
5.1.2 Phase II
5.1.3 Phase III
5.1.4 Phase IV
5.2 By Therapeutic Area
5.2.1 Oncology
5.2.2 Cardiovascular
5.2.3 Central Nervous System
5.2.4 Endocrine
5.2.5 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ICON plc
6.1.2 BBK Worldwide
6.1.3 Antidote Technologies, Inc.
6.1.4 IQVIA
6.1.5 ClinicalConnection
6.1.6 AutoCruitment
6.1.7 M&B Sciences, Inc.
6.1.8 Worldwide Clinical Trials
6.1.9 Biorasi, LLC.
6.1.10 Elligo Health Research
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Clinical Trial Patient Recruitment Services Industry Segmentation
As per the scope of the report, clinical trial patient recruitment services encompass a range of strategies, activities, and specialized services aimed at identifying, engaging, and enrolling participants for clinical trials conducted by pharmaceutical companies, contract research organizations (CROs), academic institutions, and other research entities.
The clinical trial patient recruitment services market is segmented by phase, therapeutic area, and geography. By phase, the market is segmented into phase I, phase II, phase III and phase IV. By therapeutic area, the market is segmented into oncology, cardiovascular, central nervous system, endocrine, and others. The other therapeutics areas include musculoskeletal diseases, respiratory diseases and infectious diseases among others. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America. For each segment, the market sizing and forecasts have been done on the basis of value (in USD).
| By Phase | |
| Phase I | |
| Phase II | |
| Phase III | |
| Phase IV |
| By Therapeutic Area | |
| Oncology | |
| Cardiovascular | |
| Central Nervous System | |
| Endocrine | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Clinical Trial Patient Recruitment Services Market Research FAQs
How big is the Clinical Trial Patient Recruitment Services Market?
The Clinical Trial Patient Recruitment Services Market size is expected to reach USD 3.26 billion in 2024 and grow at a CAGR of 8.22% to reach USD 4.84 billion by 2029.
What is the current Clinical Trial Patient Recruitment Services Market size?
In 2024, the Clinical Trial Patient Recruitment Services Market size is expected to reach USD 3.26 billion.
Who are the key players in Clinical Trial Patient Recruitment Services Market?
ICON plc, BBK Worldwide, Antidote Technologies, Inc., IQVIA and ClinicalConnection are the major companies operating in the Clinical Trial Patient Recruitment Services Market.
Which is the fastest growing region in Clinical Trial Patient Recruitment Services Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Clinical Trial Patient Recruitment Services Market?
In 2024, the North America accounts for the largest market share in Clinical Trial Patient Recruitment Services Market.
What years does this Clinical Trial Patient Recruitment Services Market cover, and what was the market size in 2023?
In 2023, the Clinical Trial Patient Recruitment Services Market size was estimated at USD 2.99 billion. The report covers the Clinical Trial Patient Recruitment Services Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Clinical Trial Patient Recruitment Services Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Clinical Trial Patient Recruitment Services Industry Report
Statistics for the 2024 Clinical Trial Patient Recruitment Services market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Clinical Trial Patient Recruitment Services analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
